|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 94.26 USD | +1.83% |
|
+2.46% | -6.52% |
| 05-18 | Wells Fargo Adjusts PT on Clorox Company to $95 From $100, Maintains Equalweight Rating | MT |
| 05-12 | BNP Paribas Adjusts Price Target on Clorox Company to $97 From $128, Maintains Neutral Rating | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- CLX Stock
- Consensus The Clorox Company
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition